Skip To Main Content
Adam Bonislawski on Muck Rack

Adam Bonislawski

Verified
New York, United States
As seen in: 360Dx, GenomeWeb, The Wall Street Journal, New York Post, Yahoo Finance, MarketWatch, House Party (Podcast), Observer, Literary Hub, Mansion Global, Commercial Observer, Modern Healthcare and
Thought follower; reporter for @360DxNews, @GenomeWeb; writing a book about cancer early detection to be published by @orbooks in 2023.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Adam

Contact Adam, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

GenomeWeb Top 40 Jumps 6 Percent in July, Outpacing Broader Market

|
By Adam Bonislawski Verified
| GenomeWeb Verified
We have added Alamar Biosciences to the GenomeWeb Top 40 and removed OraSure Technologies. NEW YORK – Share prices of the omics, diagnostics, and clinical laboratory companies tracked by the GenomeWeb Top 40 rose 6 percent on average month over month in July, as the life science tools and diagnostics segments well outpaced the broader market. The Dow Jones Industrial Average rose less than 1 percent month over month, the Nasdaq fell 3 percent, and the Nasdaq Biotech Index fell 2 percent.
Open in Who Shared View Duplicates (2) Issue with article?

At ADLM, Lab Stakeholders Grapple With Regulation, Reimbursement of AI-Based Testing

|
By Adam Bonislawski Verified
| 360Dx Verified
ANAHEIM, Calif. — As artificial intelligence continues to penetrate the clinical laboratory, regulators, payors, and industry stakeholders are grappling with how to handle the emerging technology. Recent months have seen efforts from organizations including Congress, the US Centers for Medicare and Medicaid Services (CMS), and the American Medical Association (AMA) to establish pathways for regulating and reimbursing AI-based tests.
Open in Who Shared Issue with article?

Liquid Biopsy Testing Labs Face Staffing Challenges as Demand Explodes

|
By Adam Bonislawski Verified
| GenomeWeb Verified
NEW YORK – As the liquid biopsy space has exploded in recent years, clinical laboratories are struggling to find sufficient staff to oversee and run these assays. Staffing is a problem for the clinical lab industry writ large, but rapid growth in demand and quickly evolving technology have made liquid biopsy a particularly tricky area.
Open in Who Shared Issue with article?
See all 1,014 articles